(0.29%) 5 195.86 points
(0.17%) 38 919 points
(0.20%) 16 381 points
(0.55%) $78.91
(-0.32%) $2.19
(-0.48%) $2 320.00
(-0.24%) $27.55
(2.39%) $987.95
(0.12%) $0.929
(0.71%) $10.90
(0.38%) $0.799
(-0.05%) $91.30
0.96% € 39.80
Live Chart Being Loaded With Signals
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide...
Stats | |
---|---|
Volumen de hoy | 37 401.00 |
Volumen promedio | 59 792.00 |
Capitalización de mercado | 828.89M |
EPS | €0 ( 2024-03-21 ) |
Próxima fecha de ganancias | ( €0 ) 2024-05-13 |
Last Dividend | €0.500 ( 2023-06-08 ) |
Next Dividend | €0 ( N/A ) |
P/E | 27.26 |
ATR14 | €0.0550 (0.14%) |
Volumen Correlación
Eckert & Ziegler Strahlen Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eckert & Ziegler Strahlen Correlación - Moneda/Commodity
Eckert & Ziegler Strahlen Finanzas
Annual | 2023 |
Ingresos: | €246.09M |
Beneficio Bruto: | €116.34M (47.28 %) |
EPS: | €1.260 |
FY | 2023 |
Ingresos: | €246.09M |
Beneficio Bruto: | €116.34M (47.28 %) |
EPS: | €1.260 |
FY | 2022 |
Ingresos: | €222.26M |
Beneficio Bruto: | €106.78M (48.04 %) |
EPS: | €1.410 |
FY | 2021 |
Ingresos: | €180.44M |
Beneficio Bruto: | €91.08M (50.48 %) |
EPS: | €1.670 |
Financial Reports:
No articles found.
Eckert & Ziegler Strahlen Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.500 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.113 | 2002-05-27 |
Last Dividend | €0.500 | 2023-06-08 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | €5.52 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.17 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.90 | |
Div. Directional Score | 8.19 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
FMV.DE | Ex Dividend Junior | 2023-08-15 | Quarterly | 0 | 0.00% | |
PSAN.DE | Ex Dividend Junior | 2023-05-24 | Sporadic | 0 | 0.00% | |
AP2.DE | Ex Dividend Knight | 2023-11-22 | Quarterly | 0 | 0.00% | |
HP3A.DE | Ex Dividend Junior | 2023-06-21 | Annually | 0 | 0.00% | |
SOW.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
CAT1.DE | Ex Dividend Knight | 2023-07-19 | Quarterly | 0 | 0.00% | |
KTA.DE | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
V6C.DE | Ex Dividend Junior | 2023-06-01 | Annually | 0 | 0.00% | |
DR0.DE | Ex Dividend Junior | 2023-06-30 | Sporadic | 0 | 0.00% | |
NKE.DE | Ex Dividend King | 2023-09-01 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.107 | 1.500 | 7.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0599 | 1.200 | 8.00 | 9.61 | [0 - 0.3] |
returnOnEquityTTM | 0.120 | 1.500 | 9.78 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.79 | 0.800 | 1.040 | 0.832 | [1 - 3] |
quickRatioTTM | 2.31 | 0.800 | 1.089 | 0.871 | [0.8 - 2.5] |
cashRatioTTM | 0.813 | 1.500 | 6.60 | 9.90 | [0.2 - 2] |
debtRatioTTM | 0.128 | -1.500 | 7.86 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.64 | 1.000 | 6.80 | 6.80 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.28 | 2.00 | 9.24 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.015 | 2.00 | 9.49 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.253 | -1.500 | 8.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.473 | 1.000 | 5.45 | 5.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.189 | 1.000 | 8.22 | 8.22 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.842 | 1.000 | 6.43 | 6.43 | [0.2 - 2] |
assetTurnoverTTM | 0.560 | 0.800 | 9.60 | 7.68 | [0.5 - 2] |
Total Score | 11.48 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 31.20 | 1.000 | 6.95 | 0 | [1 - 100] |
returnOnEquityTTM | 0.120 | 2.50 | 9.86 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.015 | 2.00 | 9.66 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.268 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.28 | 2.00 | 9.24 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0682 | 1.500 | -3.79 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.193 | 1.000 | 7.69 | 0 | [0.1 - 0.5] |
Total Score | 4.90 |
Eckert & Ziegler Strahlen
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico